DIA 2018 Editor’s Take – WCG

Thought Leaders:

Donald A. Deieso, Chairman and CEO, WIRB-Copernicus Group
Jill Johnston, President, Site Activation, WIRB-Copernicus Group

July 31, 2018      

Dr. Deieso and Ms. Johnston discuss how Precision Medicine is impacting clinical trials, the opportunities provided by Precision Medicine, their partnership with Informed DNA, and the evolution of the Center for Genetics and Precision Medicine in Clinical Trials.

Post a Comment

You must be logged in to post a Comment.